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Evidence for the physiological functions of UCP2 and UCP3 is critically reviewed. They do not mediate adaptive thermo-
genesis, but they may be significantly thermogenic under specific pharmacological conditions. There is strong evidence
that the mild regulated uncoupling they cause attenuates mitochondrial ROS production, protects against cellular damage,
and diminishes insulin secretion. Evidence that they export fatty acids physiologically is weak. UCP2 and UCP3 are impor-
tant potential targets for treatment of aging, degenerative diseases, diabetes, and perhaps obesity.Introduction
Uncoupling proteins (UCPs) have become prominent in the
fields of thermogenesis, obesity, diabetes, and free radical biol-
ogy following the discovery of a family of novel UCPs and have
recently started to make an impact in the areas of degenera-
tive, neurological, circulatory, and immunological diseases and
aging. The new UCPs are closely related to UCP1, which cata-
lyzes adaptive thermogenesis in mammalian brown adipose
tissue by greatly increasing the proton conductance of the
mitochondrial inner membrane (Cannon and Nedergaard, 2004).
UCP1 is present at huge concentrations, up to 10% of the
membrane protein, to accomplish this. The leak of protons
through UCP1 uncouples substrate oxidation from phosphory-
lation of ADP to ATP, leading to fast oxygen consumption and
heat production. The proton conductance of UCP1 is under
tight control: it is strongly inhibited by purine nucleotides at
physiological concentrations, and this inhibition is overcome
by fatty acids released from intracellular triacylglycerol stores
following adrenergic activation in response to cold.
The discovery of UCP1 orthologs (UCP2 and UCP3) in mito-
chondria from several mammalian tissues prompted initial
speculation that these UCPs are also thermogenic and in-
volved in regulation of energy expenditure and obesity. These
reasonable speculations were based on the conservation of
residues thought to be involved in proton transport and nucleo-
tide binding. However, it is now clear that UCP2 and UCP3 are
present at tiny concentrations, 0.01% to 0.1% of the membrane
protein, and only transport protons when they are specifically ac-
tivated (Esteves and Brand, 2005). These observations, together
with the discovery of related UCPs in ectothermic fish and plants
that do not require thermogenesis, raised the possibility that
the UCPs have some different, more general function. In this
review, we consider the evidence for different models of the
physiological functions of UCP2 and UCP3. For general back-
ground, see the many reviews that are available (Boss et al.,
2000; Brand et al., 2004a, 2004b; Casteilla et al., 2001; Dulloo
and Samec, 2001; Harper et al., 2001a, 2001b; Harper and
Himms-Hagen, 2001; Horvath et al., 2003; Jezek et al., 2004;
Kozak and Harper, 2000; Nedergaard and Cannon, 2003;
Ricquier and Bouillaud, 2000a, 2000b; Saleh et al., 2002).CELL METABOLISM : AUGUST 2005 · VOL. 2 · COPYRIGHT © 2005 ELSThe reaction catalyzed by UCP2 and UCP3
There is a broad consensus that UCP2 and UCP3 do not trans-
port protons in the absence of specific activators. Evidence for
this comes from the lack of effect of UCP2 or UCP3 knockout
on the basal proton conductance of isolated mouse mito-
chondria (Cadenas et al., 2002; Couplan et al., 2002; Echtay et
al., 2002b, 2003; Krauss et al., 2003), and the very low proton
conductance in the absence of fatty acids of proteoliposomes
containing UCP2 or UCP3 (Echtay et al., 1999, 2001; Jaburek
and Garlid, 2003; Jaburek et al., 1999).
However, it is now clear that UCP2, UCP3, avian UCPs, and
plant UCPs will transport protons and increase the net proton
conductance of mitochondria in the presence of specific acti-
vators (Brand et al., 2004a, 2004b; Considine et al., 2003; Tal-
bot et al., 2003), including reactive alkenals such as hydroxy-
nonenal, which is produced by peroxidation of membrane
phospholipids (Echtay et al., 2003). The proton conductance in
the presence of these activators is inhibited by purine nucleo-
tides such as ATP and GDP. Fatty acids are probably required
for activation (Echtay et al., 2001, 2002b; Rial et al., 2004), pos-
sibly to relieve inhibition by nucleotides. Thus these UCPs cat-
alyze an inducible proton conductance in the presence of acti-
vators, but they do not increase basal proton conductance in
the absence of activators.
Measurement of the transport of fatty acid and other anions
in proteoliposomes shows that UCP2 and UCP3 can transport
anions across the mitochondrial inner membrane in a reaction
that is sensitive to nucleotide inhibition (Echtay et al., 1999;
Jaburek et al., 1999). Whether fatty-acid (or fatty-acid perox-
ide) cycling across the membrane explains net proton transport
is controversial for UCP1 (Echtay et al., 2001; Garlid et al.,
2001; Gonzalez-Barroso et al., 1998; Jaburek et al., 2001;
Klingenberg and Echtay, 2001; Klingenberg and Huang, 1999;
Rial et al., 2004; Skulachev, 1998). By extension, it is also con-
troversial for UCP2 and UCP3.
For a broader critical review of the reactions catalyzed by
UCP2 and UCP3, see Esteves and Brand (2005).
The functions of UCP2 and UCP3
What functions do UCP2 and UCP3 carry out? All models have
to accommodate the following observations:EVIER INC. DOI 10.1016/j.cmet.2005.06.002 85
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mRNA, implying that these UCPs are somehow involved
in fatty-acid metabolism (Nedergaard and Cannon, 2003).
• UCP2 and UCP3 catalyze net proton conductance, but
only when activated by fatty acids and free radical-derived
alkenals (Brand et al., 2004a, 2004b).
• UCP2 and UCP3 can probably export fatty acids and other
anions (Echtay et al., 1999; Jaburek et al., 1999).
• Mice in which UCP2 or UCP3 are knocked out show only
weak phenotypes in the laboratory (Harper and Himms-
Hagen, 2001).
Model 1: UCP2 and UCP3 increase thermogenesis
and protect against obesity
When UCP2 and UCP3 were first identified, their function was
postulated to be thermogenesis and body weight regulation
(Boss et al., 1997b; Fleury et al., 1997; Gimeno et al., 1997;
Gong et al., 1997; Vidal-Puig et al., 1997), perhaps by catalyz-
ing a constitutive basal proton leak in widespread tissues that
complemented the specialized adaptive thermogenic function
of UCP1 in brown adipose tissue (Figure 1, Model 1A). How-
ever, evidence against a thermogenic function quickly ap-
peared. UCP2 mRNA and UCP3 mRNA and protein concentra-
tion rise in muscle of starved rats, whereas thermogenesis falls
(Boss et al., 1997a, 1998; Cadenas et al., 1999; Samec et al.,
1998), and UCP homologs are found in tissues of fish (Stuart
et al., 1999) and plants (Laloi et al., 1997), ectotherms in which
adaptive thermogenesis does not occur. The most persuasive
argument comes from UCP2 and UCP3 knockout mice, which
have normal responses to cold exposure and are not obese
(Arsenijevic et al., 2000; Gong et al., 2000; Vidal-Puig et al.,
2000; Zhang et al., 2001).
There is now a consensus that the primary function of UCP2
and UCP3 is not to promote gross thermogenesis or energetic
inefficiency. However, thermogenic models should not be com-
pletely abandoned since activation of UCP3 in muscle may
cause significant thermogenesis in particular conditions. The
concentrations of UCP2 in spleen, lung, and stomach mito-
chondria (Pecqueur et al., 2001) and of UCP3 in skeletal mus-
cle mitochondria (Harper et al., 2002) are tiny: 0.1% to 1% of
the concentration of UCP1 in brown adipose tissue mito-
chondria. However, considering the much greater mass of
muscle and its large contribution to metabolic rate, the maxi-
mum thermogenic capacity of UCP3 may still be significant.
The stimulation of metabolic rate and decreased weight gain
caused by UCP3 overexpression in mouse muscle (Clapham
et al., 2000) is caused by artifactual uncoupling, but the extent
of this artifact in isolated muscle mitochondria (Cadenas et al.,
2002) happens to be similar to the extent of stimulation of
UCP3-mediated proton conductance achieved by addition of
superoxide or alkenals (Echtay et al., 2002b, 2003), suggesting
that activation of UCP3 in vivo by physiological activators or
pharmacological intervention might have the capacity to be
significantly thermogenic (Figure 1, Model 1B). In support of
this suggestion, UCP3 knockout mice have diminished muscle
hyperthermia in response to the recreational drug ecstasy
(MDMA) (Mills et al., 2003).
Birds lack brown adipose tissue and UCP1 but still have
adaptive thermogenesis. Avian UCP is 70% identical in se-
quence to mammalian UCP2 and UCP3 and is restricted to86skeletal muscle (Raimbault et al., 2001; Vianna et al., 2001).
Like these proteins, avUCP does not catalyze the basal proton
leak of mitochondria, and its proton conductance can be acti-
vated by superoxide (Talbot et al., 2003). AvUCP mRNA is in-
creased by cold exposure in hummingbirds, ducklings, and
chickens (Raimbault et al., 2001; Toyomizu et al., 2002; Vianna
et al., 2001). Its mRNA and the superoxide-inducible proton
conductance are upregulated by cold water immersion of pen-
guins (Talbot et al., 2004a). These observations are consistent
with a major role of avUCP in thermogenesis in birds (Figure
1, Model 1B). Equally, they are consistent with roles in other
thermogenesis-associated functions (Figure 1), such as fatty-
acid metabolism or attenuation of free radical generation.
How does this model accommodate the requirements listed
above? Fatty acids and alkenals might activate UCP2 and
UCP3 when thermogenesis is required; anion transport might
be part of the uncoupling cycle, or a side reaction. The lack of
a strong cold-sensitive or obese phenotype in knockout mice
argues strongly against thermogenesis being a major function.
However, it could be important under specific conditions that
were not applied in the phenotyping experiments; the lack of a
thermogenic response to MDMA in UCP3 knockout mice sup-
ports this argument.
Thus UCP2 and UCP3 are not normally thermogenic or in-
volved in the adaptive response to cold, but UCP3 might still
be significantly thermogenic under specific conditions and it
remains an attractive drug target for the treatment of obesity.
Model 2: UCPs attenuate mitochondrial production of free
radicals and protect against oxidative damage,
degenerative diseases, and aging
Mitochondria are the major source of reactive oxygen species
(ROS) in cells. ROS damage is thought to underpin several de-
generative diseases, including diabetes, Parkinson’s, Alzhei-
mer’s, and Friedrich’s ataxia, and aging itself (Brand et al.,
2004a, 2004b). Mitochondrial ROS production is very sensitive
to the protonmotive force set up across the inner membrane
by electron transport, so the mild uncoupling caused by activa-
tion of UCP2 or UCP3 might lower protonmotive force slightly,
attenuate mitochondrial ROS production, and protect against
ROS-related cellular damage (Figure 1, Model 2) (Arsenijevic et
al., 2000; Brand et al., 2002; Casteilla et al., 2001; Cortez-Pinto
et al., 1999; Echtay et al., 2002b; Kowaltowski et al., 1998;
Negre-Salvayre et al., 1997; Nicholls and Budd, 2000; Rolfe
and Brand, 1997; Skulachev, 1996, 1998; Vidal-Puig et al.,
2000). “Mild” uncoupling implies a limited increase in proton
conductance so that protonmotive force is slightly lowered and
respiration rate is slightly increased, but ATP can still be made.
It differs from full uncoupling, where protonmotive force and
ATP synthesis are abolished and respiration is maximal.
The fullest elaboration of this model (Figure 2) proposes a
specific pathway of UCP activation in response to mitochon-
drial radical production. Superoxide production from the electron
transport chain is high during fatty-acid oxidation (St-Pierre et
al., 2002). The model proposes that superoxide directly (or indi-
rectly, through formation of hydroxyl radicals) attacks n-6 poly-
unsaturated fatty acyl chains of membrane phospholipids,
chiefly arachidonic acid chains, forming carbon-centered fatty
acyl radicals. Oxidation of these carbon-centered radicals to
peroxyl radicals initiates a well-known chain reaction (Halliwell
and Gutteridge, 1999) that leads to massive production ofCELL METABOLISM : AUGUST 2005
R E V I E WFigure 1. Models of the physiological functions catalyzed by UCP2 and UCP3
The yellow rectangle represents a cell; the red circle represents the inner membrane of mitochondria within it. Fatty acids are converted to fatty acyl CoA (fa CoA) in
the matrix, then reducing equivalents ([H]) are removed by β oxidation and passed to the electron transport chain (ETC) where they are oxidized, causing proton
pumping. The resultant protonmotive force drives ATP synthesis or is dissipated by UCPs. Model 1A: in the presence of UCPs, oxidation of fuels is significantly
uncoupled from ATP synthesis, leading to increased fuel oxidation and thermogenesis. Model 1B: by analogy with activation of UCP1 in brown adipose tissue, an
appropriate signal triggers triacylglycerol breakdown, releasing fatty acids. The fatty acids are oxidized, leading to ROS production by the electron transport chain. The
ROS and fatty acids activate the proton conductance of UCP2 or UCP3, causing thermogenesis. Model 2: during fatty-acid oxidation, ROS production activates UCPs,
lowering the protonmotive force (p). ROS production is very sensitive to p, so it decreases, setting up a negative feedback loop of mild uncoupling that attenuates
ROS production when it rises too high, protecting the cell against oxidative stress. Model 3: the mild uncoupling lowers p and therefore decreases ATP synthesis. In
pancreatic β cells, this lowers ATP and raises ADP in the cytoplasm, leading to decreased insulin release. Model 4A: the primary function of UCPs is to export fatty-
acid anions generated when fatty acyl CoA is hydrolyzed by thioesterases to release the CoA needed for continued rapid fatty-acid β oxidation (red arrows). Alternatively,
the fatty-acid anions are generated by uncatalyzed entry of excess protonated fatty acids from the cytosol (green arrows) and the cycle of protonated fatty-acid entry
and fatty-acid anion export causes net proton conductance as a side reaction. Model 4B: ROS cause peroxidation of membrane phospholipids and the resulting fatty-
acid peroxide anions (HOOfa−) are exported by UCPs (red arrow). If the peroxides can protonate and return (green arrows), the cycle catalyzes net proton conductance.4-hydroxynonenal and other reactive alkenals. The alkenals ac-
tivate the proton conductance of UCPs, lowering protonmotive
force and attenuating the original superoxide production. This
provides a local feedback by which UCP2 and UCP3 control
the mitochondrial production of ROS (Brand et al., 2004a,
2004b; Echtay et al., 2002a, 2002b, 2003; Murphy et al., 2003;
Talbot et al., 2004b).
The evidence for this model is extensive. Superoxide, prod-
ucts of oxidation of membrane phospholipids such as hydroxy-
nonenal, and analogs of these products all activate the GDP-
sensitive proton conductance of UCP2 and UCP3, causingCELL METABOLISM : AUGUST 2005mild uncoupling (Brand et al., 2004a). Activation of proton con-
ductance occurs when the effects of ROS are mimicked by
addition of a carbon-centered radical generator, AAPH, and ac-
tivation by superoxide or AAPH is prevented by a spin trap
that quenches carbon-centered radicals (Murphy et al., 2003),
suggesting that a carbon-centered radical is an intermediate in
the activatory pathway. Mild uncoupling strongly decreases
ROS production (Brand, 2000; Korshunov et al., 1997; Lambert
and Brand, 2004; Liu, 1997; Miwa et al., 2003; Papa and Sku-
lachev, 1997). Inhibition of UCPs by GDP in mitochondria in-
creases membrane potential and mitochondrial ROS produc-87
R E V I E WFigure 2. A model for the physiological activation of UCP2 or UCP3 by superoxide
The mitochondrial electron transport chain pumps protons, setting up a high protonmotive force that backs up the electrons and allows them to spill onto molecular
oxygen, forming superoxide. Superoxide, or its more lipid-soluble protonated form, hydroperoxyl radical, diffuses into the inner membrane, where it attacks phospholipid
n-6 polyunsaturated fatty acyl groups such as arachidonate, extracting a hydrogen atom and leaving behind a carbon-centered fatty acyl radical. This can react with
molecular oxygen to form a lipid peroxyl radical, which initiates another round of carbon-centered radical production and breaks down to fragments including
4-hydroxynonenal. In this way, a single hydroperoxyl radical can initiate a cascade that generates a large number of hydroxynonenal molecules. The hydroxynonenal
activates the UCP, causing it to transport protons and lower the protonmotive force, leading to attenuation of superoxide production by the electron transport chain.
Based on Brand et al. (2004a).tion (Kowaltowski et al., 1998; Negre-Salvayre et al., 1997;
Talbot et al., 2004b), consistent with a role of the UCPs in
keeping ROS production low by causing mild uncoupling. Simi-
larly, mitochondria from UCP3 knockout mice show evidence
of higher ROS production (Brand et al., 2002; Vidal-Puig et al.,
2000). Thus there is strong experimental support for several
different aspects of the alkenal feedback mechanism in iso-
lated mitochondria.
Supporting evidence comes from phenotyping UCP2 knock-
out mice. These animals are resistant to infection by the in-
tracellular parasite Toxoplasma gondii through a mechanism
proposed to involve increased macrophage ROS production
(Arsenijevic et al., 2000; Richard et al., 2001). Their livers have
elevated markers of ROS production and delayed liver regener-
ation after partial hepatectomy, suggesting that UCP2 protects
against ROS (Horimoto et al., 2004). Similarly, LDL receptor
knockout mice with UCP2 knockout bone marrow have more
oxidative stress and are more susceptible to atherosclerosis
than controls, suggesting that UCP2 protects against ROS-
mediated atherosclerosis in vivo (Blanc et al., 2003), and endo-
thelial cells treated with UCP2 antisense oligonucleotides (Du-
val et al., 2002) and pancreatic islet cells from UCP2 knockout
mice (Krauss et al., 2003) have increased ROS production.
How does this model accommodate the requirements listed
above? ROS production may be particularly high when fatty
acids are oxidized (St-Pierre et al., 2002), explaining the need
for fatty-acid upregulation of gene expression. Superoxide and
alkenal activation would be signals to activate mild uncoupling
in the face of excessive ROS production. Anion transport might
be part of the uncoupling cycle, or a side reaction. The weak
phenotype may reflect low ROS-related damage in animals in88laboratory settings. However, the phenotypes that are seen im-
plicate ROS and are consistent with the model. Note that the
effects of UCP2 and UCP3 knockout on development of de-
generative diseases and aging have not been reported and
might be significant.
Thus there is good evidence that a major function of UCP2
and UCP3 is to attenuate mitochondrial production of free radi-
cals in mitochondria, in cells, and in vivo and to protect against
oxidative damage.
Model 3: UCPs mediate ROS signaling
and insulin secretion
The mild uncoupling caused by activation of UCP2 may have
a signaling role. Activation of UCP2 may attenuate glucose-
stimulated insulin secretion by pancreatic β cells. In the con-
sensus model of the major route of glucose-stimulated insulin
secretion by pancreatic β cells (Rutter, 2001), glucose catabo-
lism increases the mitochondrial protonmotive force, the cyto-
plasmic ATP/ADP ratio rises, and plasma membrane KATP
channels close, leading to depolarization, opening of voltage-
sensitive calcium channels, calcium influx, and insulin secre-
tion. UCP2 could short-circuit this pathway by mild uncoupling,
blunting the rise in protonmotive force caused by raised glu-
cose, and attenuating insulin secretion (Chan et al., 1999). A
plausible regulator of UCP2 function is fatty-acid oxidation,
which would raise β cell ROS production, activate the proton
conductance of UCP2, and attenuate insulin secretion (Figure
1, Model 3) (Brand et al., 2004a; Green et al., 2004; Lameloise
et al., 2001), while hyperglycemia may do the same pathologi-
cally (Zhang et al., 2001).
There is considerable indirect evidence that UCP2 regulatesCELL METABOLISM : AUGUST 2005
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acid oxidation. UCP2 mRNA is expressed in pancreatic islets
(Zhou et al., 1997), and β cell mitochondria show a large GDP-
sensitive superoxide-activated proton conductance (Echtay et
al., 2002b), showing that UCP2 is present and can be activated
by ROS. In β cells, fatty acids increase mitochondrial ROS pro-
duction and decrease glucose-stimulated increases in mito-
chondrial membrane potential, cellular ATP content, cytoplas-
mic calcium, and insulin secretion (Carlsson et al., 1999; Joseph
et al., 2004; Koshkin et al., 2003; Lameloise et al., 2001). Com-
pleting the circumstantial case, ROS (Sakai et al., 2003) and
hydroxynonenal (Miwa et al., 2000), activators of UCP2 (Echtay
et al., 2003), also decrease glucose-stimulated insulin secretion.
Overexpression of UCP2 is subject to gain-of-function arti-
facts (Esteves and Brand, 2005). With this important caveat,
the effects of UCP2 overexpression (Chan et al., 1999, 2001;
Hong et al., 2001; Li et al., 2001) support the suggestion that
increased UCP2 lowers mitochondrial membrane potential,
mitochondrial coupling, mitochondrial ROS production, cyto-
plasmic ATP content, and plasma membrane potassium fluxes
and attenuates glucose-stimulated insulin secretion. Even if
these overexpression effects reflect an uncoupling artifact
rather than any native function of the overexpressed UCP2,
they still show that mild uncoupling of β cells can modulate
insulin secretion by antagonizing the KATP channel pathway.
Strong and convincing evidence for this model comes from
investigations of loss of function in UCP2 knockout mice.
UCP2-deficient mice have higher islet ATP levels and increased
glucose-stimulated insulin secretion, establishing that UCP2
negatively regulates insulin secretion (Zhang et al., 2001). Fat
feeding and fatty acids attenuate glucose-stimulated increases
in mitochondrial potential, mitochondrial ROS production, ATP/
ADP ratio, cytosolic calcium, and insulin secretion. These ef-
fects of fatty acids are abolished in UCP2 knockouts, strongly
implicating UCP2 in the fatty-acid attenuation of glucose-stim-
ulated insulin secretion (Joseph et al., 2002, 2004). In wild-type
islets, endogenous superoxide activates mitochondrial proton
conductance and removal of endogenous superoxide enhances
glucose-stimulated insulin secretion. Hyperglycemia dimin-
ishes the insulin response to glucose through a superoxide-
dependent mechanism. These effects are abolished in islets
from UCP2 knockouts, showing that superoxide activation of
UCP2 proton conductance in islets attenuates insulin secretion
and mediates the suppression of insulin secretion by hypergly-
cemia (Krauss et al., 2003).
How does this model accommodate the requirements listed
above? Activation of UCP2 may mediate some of the effects
of fatty acids on insulin secretion, providing a rationale for
fatty-acid upregulation of gene expression. Superoxide and al-
kenal activation would be signals to activate mild uncoupling
when fatty acids are high. Anion transport might be part of
the uncoupling cycle, or a side reaction. The apparently weak
phenotype is not weak at all: it is marked when the effects on
insulin secretion of high fatty acids and hyperglycemia are in-
vestigated.
Thus activating the proton conductance of UCP2 by ROS
attenuates insulin secretion in pancreatic β cells. This may be
a pathological side effect of a protective mechanism that limits
ROS production and islet damage during high-fat feeding or
hyperglycemia (Model 2) and leads to type II diabetes (Joseph
et al., 2004; Krauss et al., 2003; Zhang et al., 2001). In addition,CELL METABOLISM : AUGUST 2005it may be a physiological mechanism to regulate the use of
fatty acids and glucose as fuels (Model 3) (Brand et al., 2004a).
Model 4: UCPs mediate the export of fatty acids
and fatty-acid peroxides
Model 4A. UCP3 exports fatty acids allowing high fatty-
acid oxidation rates or protecting against lipotoxicity
When fatty acids are the predominant substrate for muscle and
brown fat, they are converted to fatty acyl CoA for oxidation. If
fatty-acid supply exceeds the oxidation rate, fatty acyl CoA
might accumulate in the mitochondria and limit further fatty-
acid β oxidation because of lack of free CoA. To circumvent
this, acyl CoA is hydrolyzed within the mitochondria to fatty-
acid and free CoA. In this model, the fatty-acid anion is ex-
ported to the cytosol by UCP3, allowing continued rapid fatty-
acid β oxidation in the face of any oversupply (Figure 1, Model
4A) (Himms-Hagen and Harper, 2001).
A related hypothesis suggests that when fatty-acid supply is
high, fatty acids protonate and flip into mitochondria, where
they accumulate up to ten-fold because of the pH gradient.
They cannot be metabolized because of the lack of matrix acyl
CoA synthases and may be toxic. UCP3 would export the
fatty-acid anions, which in principle could lower the matrix
concentration more than 1000-fold. The cycle of protonated
fatty-acid entry and deprotonated fatty-acid anion export would
cause net proton influx as a secondary side reaction rather
than as the primary function (Figure 1, Model 4A) (Schrauwen
and Hesselink, 2004).
In our opinion, the evidence for these hypotheses is entirely
circumstantial. The hypotheses are consistent with observa-
tions that UCP3 can transport anions (Esteves and Brand,
2005). They are supported by observations that UCP3 expres-
sion is upregulated by long-chain fatty acids and tends to cor-
relate with the oxidation of fatty acids and the expression of
other genes involved in fatty-acid oxidation (Himms-Hagen and
Harper, 2001; Schrauwen and Hesselink, 2004). However, the
correlations with fatty-acid metabolism are equally well ex-
plained by Model 2 (attenuation of ROS production), so the
correlations cannot be taken as evidence in favor of or against
either model.
How do these models accommodate the requirements listed
above? They explain the fatty-acid upregulation of gene ex-
pression and the anion transport by UCP3, but not why super-
oxide and alkenals activate the proton conductance of UCP3.
They predict inhibition of fatty-acid oxidation or enhanced lipo-
toxicity in UCP knockouts, but this has not been observed de-
spite specific tests of high-fat diets. However, it may be that
some particular aspect of the conditions under which this func-
tion is recruited was not in place in these experiments.
Thus these hypotheses are consistent with physiological
data correlating fatty-acid oxidation and UCP3 expression, but
they lack the much stronger evidence that comes from knock-
out phenotypes, and they fail to explain the ROS-associated
properties of UCP3 discussed above. They need to be sup-
ported by more direct tests if they are to be serious contenders.
Model 4B. UCP2 and UCP3 catalyze the export
of fatty-acid peroxides
The polyunsaturated fatty-acid side chains of membrane phos-
pholipids are very sensitive to oxidation and can form aggres-
sive oxidants such as hydroxynonenal that damage mitochon-
drial proteins and DNA. If UCP2 and UCP3 were to export89
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pholipids by phospholipases, they could rid the inner leaflet of
the mitochondrial membrane of damaging peroxides, leaving
them more safely in the outer leaflet (Figure 1, Model 4B) (Gog-
lia and Skulachev, 2003).
In an extension of this hypothesis, if the exported fatty-acid
peroxides could protonate and flip back across the membrane,
UCPs would catalyze net proton transport (Figure 1, Model 4B)
(Jaburek et al., 2004).
The first model does not explain the observed net proton
transport. It could explain changes in ROS production by mito-
chondria as the result rather than the cause of oxidative dam-
age. The hypothesis that fatty-acid peroxide cycling across the
membrane causes net proton transport is a variant of the fatty-
acid cycling model that provides an alternative mechanistic ex-
planation for the activation of UCPs by ROS; the evidence for
the function of net proton transport in attenuating ROS produc-
tion and ROS-related damage is discussed above. These mod-
els explain anion transport by UCPs, but whether they are cor-
rect awaits further experimentation.
Conclusions
It is clear that UCP2 and UCP3 increase the proton conduc-
tance of the mitochondrial inner membrane, but only when they
are activated by products of ROS metabolism such as hy-
droxynonenal, and perhaps by fatty acids. Most importantly,
they do not affect the basal proton conductance of the mem-
brane in the absence of these activators. Many studies on the
function of UCPs measure only mRNA levels, but it follows that
changes in mRNA or even protein levels for UCPs cannot pre-
dict the functional effect (as this will depend on the activation
state of the protein in situ) but can only predict the capacity of
the protein for activation.
UCP2 and UCP3 are not generally responsible for adaptive
thermogenesis, but nonetheless they may be significantly ther-
mogenic when fully activated by endogenous or exogenous
effectors. There is strong evidence that the mild regulated
uncoupling they cause is responsible for attenuating mitochon-
drial ROS production and protecting against ROS-induced
cellular damage, and for diminishing insulin secretion by pan-
creatic β cells. The effect on insulin secretion may be a patho-
logical side reaction of the ROS-attenuating function, but a
more attractive hypothesis is that it represents an important
physiological regulator of insulin secretion in β cells. In an ex-
tension of this idea, UCP2 may have a general role in attenuat-
ing secretory or excitatory function in cells that use ATP or ADP
as internal signals of energy supply, for example, in specific
cells in the brain, such as hypothalamic neurons, which display
glucose-dependent excitation and neuropeptide secretion. It
could also modulate ROS production by mitochondria, which
may be used as a signal for regulating gene expression. The
evidence that UCP2 and UCP3 are involved physiologically in
fatty-acid (peroxide) anion export is weak and circumstantial
and needs to be improved before hypotheses based on this
model can be accepted.
Now that at least some of the physiological functions of
UCP2 and UCP3 have been identified, their importance in hu-
man physiology, pathology, and medicine is becoming clearer.
They remain important targets for activation to treat obesity or
for inhibition to treat weight loss (or to improve feed efficiency
in domesticated animals). Enhancing their expression and their90activity by nontoxic ROS analogs may become an important
way to attenuate mitochondrial ROS production and the con-
sequent oxidative damage that may underlie normal aging and
contribute to a variety of degenerative diseases. Inhibiting the
expression or activity of UCP2 may protect against inadequate
insulin secretion caused by hyperglycemia or lipotoxicity in
pancreatic β cells in diabetes. Clearly, some of these prospects
are mutually incompatible, so further understanding of the con-
ditions under which the proteins operate and careful design
and targeting of activators and inhibitors will be required to
ensure that only the beneficial effects are enhanced in any ther-
apies that may be developed.
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